BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19460106)

  • 1. The effects of butyrate enemas on visceral perception in healthy volunteers.
    Vanhoutvin SA; Troost FJ; Kilkens TO; Lindsey PJ; Hamer HM; Jonkers DM; Venema K; Brummer RJ
    Neurogastroenterol Motil; 2009 Sep; 21(9):952-e76. PubMed ID: 19460106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans.
    Hamer HM; Jonkers DM; Bast A; Vanhoutvin SA; Fischer MA; Kodde A; Troost FJ; Venema K; Brummer RJ
    Clin Nutr; 2009 Feb; 28(1):88-93. PubMed ID: 19108937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of two types of antidepressants, amitriptyline and fluoxetine, on anorectal motility and visceral perception.
    Siproudhis L; Dinasquet M; Sébille V; Reymann JM; Bellissant E
    Aliment Pharmacol Ther; 2004 Sep; 20(6):689-95. PubMed ID: 15352918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: the role of butyrate on colonic function.
    Hamer HM; Jonkers D; Venema K; Vanhoutvin S; Troost FJ; Brummer RJ
    Aliment Pharmacol Ther; 2008 Jan; 27(2):104-19. PubMed ID: 17973645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrate enemas do not affect human colonic MUC2 and TFF3 expression.
    Hamer HM; Jonkers DM; Renes IB; Vanhoutvin SA; Kodde A; Troost FJ; Venema K; Brummer RJ
    Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1134-40. PubMed ID: 20461009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission.
    Hamer HM; Jonkers DM; Vanhoutvin SA; Troost FJ; Rijkers G; de Bruïne A; Bast A; Venema K; Brummer RJ
    Clin Nutr; 2010 Dec; 29(6):738-44. PubMed ID: 20471725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acarbose raises serum butyrate in human subjects with impaired glucose tolerance.
    Wolever TM; Chiasson JL
    Br J Nutr; 2000 Jul; 84(1):57-61. PubMed ID: 10961161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red chili induces rectal hypersensitivity in healthy humans: possible role of 5HT-3 receptors on capsaicin-sensitive visceral nociceptive pathways.
    Gonlachanvit S; Fongkam P; Wittayalertpanya S; Kullavanijaya P
    Aliment Pharmacol Ther; 2007 Aug; 26(4):617-25. PubMed ID: 17661765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans.
    Delgado-Aros S; Chial HJ; Camilleri M; Szarka LA; Weber FT; Jacob J; Ferber I; McKinzie S; Burton DD; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G558-66. PubMed ID: 12631557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans.
    Houghton LA; Cremonini F; Camilleri M; Busciglio I; Fell C; Cox V; Alpers DH; Dewit OE; Dukes GE; Gray E; Lea R; Zinsmeister AR; Whorwell PJ
    Neurogastroenterol Motil; 2007 Sep; 19(9):732-43. PubMed ID: 17727393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial.
    Steinhart AH; Hiruki T; Brzezinski A; Baker JP
    Aliment Pharmacol Ther; 1996 Oct; 10(5):729-36. PubMed ID: 8899080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-chain fatty acid enemas fail to decrease colonic hypersensitivity and inflammation in TNBS-induced colonic inflammation in rats.
    Tarrerias AL; Millecamps M; Alloui A; Beaughard C; Kemeny JL; Bourdu S; Bommelaer G; Eschalier A; Dapoigny M; Ardid D
    Pain; 2002 Nov; 100(1-2):91-7. PubMed ID: 12435462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of butyrate or glutamine in enema solution reduces inflammation and fibrosis in experimental diversion colitis.
    Pacheco RG; Esposito CC; Müller LC; Castelo-Branco MT; Quintella LP; Chagas VL; de Souza HS; Schanaider A
    World J Gastroenterol; 2012 Aug; 18(32):4278-87. PubMed ID: 22969190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre.
    Scharlau D; Borowicki A; Habermann N; Hofmann T; Klenow S; Miene C; Munjal U; Stein K; Glei M
    Mutat Res; 2009; 682(1):39-53. PubMed ID: 19383551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis.
    Scheppach W; Sommer H; Kirchner T; Paganelli GM; Bartram P; Christl S; Richter F; Dusel G; Kasper H
    Gastroenterology; 1992 Jul; 103(1):51-6. PubMed ID: 1612357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
    Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topical butyrate on rectal epithelial kinetics and mucosal enzyme activities.
    Gibson PR; Kilias D; Rosella O; Day JM; Abbott M; Finch CF; Young GP
    Clin Sci (Lond); 1998 Jun; 94(6):671-6. PubMed ID: 9854467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of defecation: effects of coffee use and nicotine on rectal tone and visceral sensitivity.
    Sloots CE; Felt-Bersma RJ; West RL; Kuipers EJ
    Scand J Gastroenterol; 2005 Jul; 40(7):808-13. PubMed ID: 16109656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal fecal impaction treatment in childhood constipation: enemas versus high doses oral PEG.
    Bekkali NL; van den Berg MM; Dijkgraaf MG; van Wijk MP; Bongers ME; Liem O; Benninga MA
    Pediatrics; 2009 Dec; 124(6):e1108-15. PubMed ID: 19948614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.